NIH Revises Funding Strategy for Young Researchers

The agency plans to ease restrictions on grants to a narrowly defined group of early- and mid-career researchers.

katya katarina zimmer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA COMMONS, NATIONAL CANCER INSTITUTEAfter announcing a plan this May to award 400 additional grants each year to early- and mid-career scientists who fall within a specific definition, the National Institutes of Health (NIH) decided to revise its funding strategy at an advisory board meeting last Friday (December 15). The agency now aims to focus funds on researchers who are struggling to keep their labs afloat, regardless of age.

“Age should not matter,” NIH Principal Deputy Director Larry Tabak said in last week’s meeting, according to Science.

For the NIH, this is the third shift in funding policy this year. In May, the agency announced a plan to cap the number of grants a principal investigator could receive in order to create more opportunities for scientists in their early careers and those struggling to keep their labs running. The cap was planned to be set at 21 points on the Grant Support Index, a metric that quantifies grants using a point system rather than dollars. This would equate to three standard R01 grants.

After receiving criticism from senior scientists who expressed concern that the policy would hamper especially productive labs, the NIH abandoned the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • katya katarina zimmer

    Katarina Zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field. Following an internship with The Scientist in 2017, she has been happily freelancing for a number of publications, covering everything from climate change to oncology.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide